Advertisement
News
Subscribe to MDT Magazine News

'Uncertainty' over future of Neurostream joint venture with Otto Bock: Victhom

August 27, 2010 10:45 am | by The Associated Press | Comments

Victhom Human Bionics Inc. (TSXV:VHB) says there is "uncertainty" over whether Neurostream Technologies, its joint venture partnership to develop products to treat conditions such as sleep apnea, can continue as a going concern.The Quebec-based company, which reported its financial results...

FDA stalls ImmunoGen-linked breast cancer therapy approval

August 27, 2010 10:32 am | by Mass High Tech: The Journal of New England Technology | Comments

The U.S. Food and Drug Administration has sent a Refuse to File letter to Genentech Inc., which is licensing Targeted Antibody Payload (TAP) technology from Waltham-based ImmunoGen Inc., for accelerated approval of its breast cancer treatment.

Medical Action Industries completes Avid buyout

August 27, 2010 9:45 am | by The Associated Press | Comments

Medical Action Industries Inc., medical and surgical products supplier, said Friday it completed the buyout of Avid Medical Inc. for $62.5 million in cash, plus transaction costs. Avid makes custom procedure trays serving the health care industry. Medical Action said the buyout will increase its...

Advertisement

Idera to net $3.8M milestone pay from Merck

August 27, 2010 9:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Idera Pharmaceuticals Inc. is due about $3.8 million from Germany's Merck KGaA, following the Cambridge biotech's milestone achievement under a global licensing agreement.

Misonix Announces New Distribution Agreement for Russia

August 27, 2010 9:32 am | by Bio-Medicine.Org | Comments

FARMINGDALE, N.Y., Aug. 27 /- Misonix, Inc. (Nasdaq: MSON ), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has entered into a new, three year, exclusive distribution agreement with Martin-Medtechnika LLC, doing...

TOPICS:

FDA Safety Notification: Mammography Problems at Medisound, Inc. in Kissimmee, Florida

August 27, 2010 7:30 am | by U.S. Food & Drug Administration | Comments

The FDA has become aware of problems associated with the quality of mammograms performed at the Medisound, Inc. facility, located at 301 North John Young Parkway, Kissimmee, Florida 34741...

TOPICS:

Charles River Labs in $300M stock repurchase program

August 27, 2010 6:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Charles River Laboratories International Inc., a Wilmington provider of outsourced laboratory and research services, has begun an accelerated stock repurchase program to buy back $300 million worth of common stock.

Specialty Surgical Instrumentation Launches New Interactive Web Site

August 27, 2010 6:35 am | by Bio-Medicine.Org | Comments

NASHVILLE, Tenn., Aug. 27 /- Specialty Surgical Instrumentation, Inc. (SSI) a division of Symmetry Medical Inc. (NYSE: SMA ) and leading provider of surgical instruments and sterilization products, announced today the launch of a new interactive, e-commerce Web site at www.specsurg.com ....

TOPICS:
Advertisement

Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

August 27, 2010 6:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Aug. 27 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced that on August 25, 2010 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options...

TOPICS:

Novartis receives FDA approval of Tekamloâ„¢, a single-pill combination of aliskiren and amlodipine to treat high blood pressure

August 27, 2010 6:33 am | by Bio-Medicine.Org | Comments

EAST HANOVER, N.J., Aug. 27 /- The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used...

TOPICS:

Shire Announces European Approval of VPRIV & #174; (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease

August 27, 2010 6:33 am | by RealWire | Comments

Cambridge, MA, US - August, 27th 2010 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV® (velaglucerase alfa), a human cell line derived enzyme replacement...

TOPICS:

Landauer, Inc. Declares Regular Cash Dividend

August 27, 2010 6:32 am | by Bio-Medicine.Org | Comments

GLENWOOD, Ill., Aug. 27 /- Landauer, Inc. (NYSE: LDR ) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.5375 per share for the fourth quarter of fiscal 2010.  The dividend will be paid on October 2, 2010, to shareholders of record on...

TOPICS:

Innovnano announces the construction of a new nanomaterials plant

August 26, 2010 11:33 pm | by I-Micronews | Comments

Innovnano presented a project for the construction of a new plant for the synthesis of nanomaterials.

Nanocomp Technologies awarded phase II critical SBIR contract by United States air force

August 26, 2010 10:32 pm | by I-Micronews | Comments

Program Works to Scale Up Production, Optimize Properties of Large-Format Carbon Nanotube Sheets for Future Use in Manned and Unmanned Aircraft

Nanophase Technologies and Altana AG enter into new supply agreement

August 26, 2010 10:32 pm | by I-Micronews | Comments

ROMEOVILLE, Ill., Nanophase Technologies Corporation, a technology leader in nanomaterials and advanced nanoengineered products, announced today that Nanophase and its partner, the German specialty chemical company Altana AG (through its subsidiary BYK Chemie GmbH) have entered into a new...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading